Additional Proxy Soliciting Materials (definitive) (defa14a)
April 28 2020 - 4:55PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
14A
Proxy
Statement Pursuant to Section 14(a) of
the
Securities Exchange Act of 1934 (Amendment No. )
Filed
by the Registrant [X]
Filed
by a Party other than the Registrant [ ]
Check
the appropriate box:
[ ]
|
Preliminary
Proxy Statement
|
[ ]
|
Confidential,
for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
[ ]
|
Definitive
Proxy Statement
|
[X]
|
Definitive
Additional Materials
|
[ ]
|
Soliciting
Material under §240.14a-12
|
Cocrystal
Pharma, Inc.
(Name
of Registrant as Specified In Its Charter)
(Name
of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment
of Filing Fee (Check the appropriate box):
[X]
|
No
fee required.
|
|
|
[ ]
|
Fee
computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
(1)
|
Title
of each class of securities to which transaction applies:
|
|
|
|
|
(2)
|
Aggregate
number of securities to which transaction applies:
|
|
|
|
|
(3)
|
Per
unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which
the filing fee is calculated and state how it was determined):
|
|
|
|
|
(4)
|
Proposed
maximum aggregate value of transaction:
|
|
|
|
|
(5)
|
Total
fee paid:
|
|
|
|
[ ]
|
Fee
paid previously with preliminary materials.
|
|
|
[ ]
|
Check
box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting
fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date
of its filing.
|
|
(1)
|
Amount
Previously Paid:
|
|
|
|
|
(2)
|
Form,
Schedule or Registration Statement No.:
|
|
|
|
|
(3)
|
Filing
Party:
|
|
|
|
|
(4)
|
Date
Filed:
|
|
|
|
*** Exercise Your Right
to Vote ***
Important Notice Regarding the Availability
of Proxy Materials for the
Shareholder Meeting to Be Held on June
09, 2020.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
COCRYSTAL PHARMA, INC.
|
|
Meeting Information
|
|
|
Meeting Type:
|
Annual Meeting
|
|
|
|
|
For holders as of:
|
April 20, 2020
|
|
|
|
|
Date: June 09, 2020
|
Time: 2:00 p.m. EST
|
|
COCRYSTAL PHARMA, INC.
19805 North Creek Parkway
Bothell, WA 98011
|
|
|
Location:
|
Meeting
live via the Internet– please visit
www.virtualshareholdermeeting.com/COCP2020
|
|
|
|
You are receiving this communication because
you hold shares in the above named company.
This is not a ballot. You cannot use
this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that
are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request
a paper copy (see reverse side).
|
|
|
|
|
|
|
|
|
We encourage you to access and review all of the important information contained in the proxy materials before voting.
|
|
|
|
|
|
|
|
See the reverse side of this notice to obtain proxy materials and voting instructions.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Before You Vote
How
to Access the Proxy Materials
|
|
|
|
Proxy Materials Available to VIEW or RECEIVE:
1. Notice & Proxy Statement
2. Annual Report on Form 10-K
|
|
|
|
How to View Online:
|
|
|
|
Have
the information that is printed in the box marked by the arrow à
(located
on the following page) and visit: www.proxyvote.com.
|
|
|
|
How to Request and Receive a PAPER or E-MAIL Copy:
If you want to receive a paper or e-mail copy of these documents,
you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:
|
|
|
|
1)
|
BY INTERNET:
|
www.proxyvote.com
|
|
|
|
|
2)
|
BY TELEPHONE:
|
1-800-579-1639
|
|
|
|
|
3)
|
BY E-MAIL*:
|
Sendmaterial@proxyvote.com
|
|
|
|
|
*If
requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the
arrow à
(located
on the following page) in the subject line.
|
|
|
|
Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before May 26, 2020 to facilitate timely delivery.
|
|
|
How To Vote
Please Choose One of the Following Voting Methods
|
|
|
Vote In Person: Many shareholder meetings have attendance requirements
including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the
meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote
these shares.
|
|
Vote
By Internet: To vote now by the Internet, go to www.proxyvote.com. Have the information
that is printed in the box marked by the arrow à
available and follow the instructions.
|
|
Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
VOTING
ITEMS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The
Board of
Directors recommends you vote FOR all listed nominees
|
|
|
|
|
|
|
|
|
|
|
|
|
1.
|
Elect
five members to our Board of Directors for a one-year term expiring at the next annual
meeting of shareholders.
Nominees:
01)
Gary Wilcox 02) Phillip Frost 03) Roger Kornberg 04) Steve
Rubin 05) Anthony Japour
The
Board of Directors recommends you vote FOR proposal 2:
|
|
|
2.
|
Ratify
the appointment of Weinberg & Company, P.A., as our independent registered public accounting firm for the fiscal year
ending December 31, 2020.
NOTE:
Transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
|
|
Cocrystal Pharma (NASDAQ:COCP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cocrystal Pharma (NASDAQ:COCP)
Historical Stock Chart
From Apr 2023 to Apr 2024